Blog / Archives
No Confirmed Trading Bottom In Biotech Yet: Biotech ETF Review..Update-1
Update at Close 4/15….. Late Day Reversal To Green The NASDAQ Composite began a rally at 1P EDT and never stopped , moving up 62 points to close at 4034. Biotech ETFs followed step by step to end up...
Biotech Rout Not Surprising: Surveying The Damage
Top Ten Reasons For Biotech Correction NASDAQ at 4022,IBB at 221 A Sentiment Driven Market We have been writing about the bull market in biotech stocks since its inception in March 2009 when quality...
Risk Reversal: Bargain Hunting and FOMC Catalyst Perks Up Biotech Stocks… Update-1
Update 4/10 Abrupt Sell-Off --Failure to Confirm Bottom NASDAQ down 71 pts 1.7% All of yesterdays' gains wiped out and we are back to January levels. Raise cash levels to 30% on life science...
Seeking A Technical Bottom For Biotech Stocks….. Update 4/9 Rally
NASDAQ Up 0.37% to 4133 Green screen alert with large cap biotechs. Time to cover hedges. Alexion (ALXN) up 2.23% Biogen (BIIB) Up 2.4% Celgene (CELG) up 3.61% Clovis Oncology (CLVS) up 2.85% Gilead...
Rayno Life Science: Tools and Diagnostics Q1 2014 Performance
Caution As Life Science Stocks Are Consolidating Life science stocks had a wild roller coaster ride in 2014 with many stocks peaking around March 1. Momentum and cult stocks in our portfolio still...
Biotech Sell-Off Resumes: Caution Update 4/4
Update 4/4/14 Breach of Technicals-A Tad Below Early February Support Glut of Biotech IPOs Causing Indigestion? Momentum Days Are So Over NASDAQ Down 1.34% The volatile and speculative SPDR S&P...
Rayno Biopharmaceutical Stocks Q1 2014 Performance
Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and...
Large Cap Biopharmaceutical Stocks Will Lead The Way Up
Large Cap Biopharmaceutical Growth Stocks With the MoMo days over the next earnings cycle (Q1,Q2 2014) should give us better clarity on winners for 2014.On the last day of March all of these large...
Biotechs Weaker As Day Wears On: Counter-trend Green Movers
12:15p EDT 3/26 With NASDAQ down 0.64% and the IBB down 0.6% here are some green stocks: Rayno Life Science Portfolio: AMGN up 0.53%, CPHD up 1.43%, GILD up 0.57%, and REGN up 0.84%. Other...
Biotech Stocks Holding At February Lows- Still Up 9% YTD
(See Full Article in Seeking Alpha 3/26) Biopharmaceutical Downdraft 15% From February Highs (IBB$239) Large Cap Biopharmaceutical Stocks Are Core Holdings: ABBV, AMGN, GILD The biotech frenzy of...